Keywords: medigene, says, wart, drug, cuts, recurrence, german

MediGene says wart drug cuts recurrence

Article | 14 January 2002

Print This

German biopharmaceutical company MediGene has reported the recurrencedata from its Phase III trial of Polyphenon E, a candidate treatment for ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in